A new research paper was published in Volume 16 of Oncotarget on June 17, 2025, titled "Molecular landscape of HER2-mutated ...

A study led by Dana-Farber Cancer Institute researchers found that combining chemotherapy and immunotherapy before surgery ...

Elevated NLR may no longer predict poor survival outcomes in patients with small cell lung cancer (SCLC) receiving ...

Low-grade serous ovarian cancer (LGSC), accounts for just 5% to 10% of all epithelial ovarian cancers, but its distinct ...

Lung cancer is the leading cause of cancer-related mortality globally. Although low-dose computed tomography (LDCT) has shown ...

In May 2025, the Journal for ImmunoTherapy of Cancer published a pioneering study entitled "NeoPred: dual-phase CT AI forecasts pathologic response to ...

Investigators used previous trial data to compare patients receiving the chimeric antigen receptor (CAR) T-cell therapy ...

The aim is to find and treat lung cancers early, before they grow and spread, to improve the chance of survival. Here’s what’s involved.

Early postoperative levels of IL-6 and CRP are independently associated with infection risk after pulmonary cancer surgery.

Objectives To examine the accuracy and impact of artificial intelligence (AI) software assistance in lung cancer screening using CT. Methods A systematic review of CE-marked, AI-based software for ...

The FDA has granted accelerated approval to datopotamab deruxtecan (Datroway) for adults with locally advanced or metastatic non-small cell lung cancer that carries an EGFR mutation and has progressed ...

Cancer is a disease where abnormal cells grow uncontrollably and can invade other parts of the body. One of the most ...